How do anticoagulants impact the management of systemic lupus erythematosus (SLE) patients, particularly in preventing thrombotic complications associated with the condition?
Gaurav ChauhanContributor
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Anticoagulants are essential in managing SLE patients with antiphospholipid syndrome (APS), reducing the risk of thrombosis, a common and serious complication of SLE.